Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7292)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 15, 2021 (publication date) through Jan 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Roy A, Sahoo J, Narayanan N, Merugu C, Kamalanathan S, Naik D. Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence. World J Diabetes 2021; 12(9): 1426-1441 [PMID: 34630898 DOI: 10.4239/wjd.v12.i9.1426] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i9/1426.htm |
| Number | Citing Articles |
| 1 |
Kayo Masuko. Glucose as a Potential Key to Fuel Inflammation in Rheumatoid Arthritis. Nutrients 2022; 14(11): 2349 doi: 10.3390/nu14112349
|
| 2 |
Maria Rosa Noliza Encarnacion, Ryota Kawai, Hiroto Kuwabiraki, Nanaka Ban, Hisako Yoshida, Ayumi Shintani, Daisuke Tsuruta, Sho Hiroyasu. Clinical characteristics and outcomes of autoimmune blistering diseases in Japan. The Journal of Dermatology 2024; doi: 10.1111/1346-8138.17518
|
| 3 |
H. Kang, E. B. Lee, S. Lee, T. ‐H. Go, J. Y. Lee, S. ‐H. Lee, S. A. Song, H. K. Lim, S. ‐P. Hong. Dipeptidyl peptidase‐4 inhibitors increase the risk of bullous pemphigoid in older patients with diabetes: A retrospective analysis using the Korean National Health Insurance Database. Journal of the European Academy of Dermatology and Venereology 2023; 37(7) doi: 10.1111/jdv.18975
|
| 4 |
M. Ganeva. SAFETY PROFILE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS. Trakia Journal of Sciences 2023; 21(1): 54 doi: 10.15547/tjs.2023.01.009
|
| 5 |
Neslihan USLU, Kagan GUNGOR, Gonca TAMER, Bulent CAN. Association of Dipeptidiyl Peptidase-4 Inhibitors and Bullose Pemphigoid: A Report of Four Cases. Medeniyet Medical Journal 2024; : 140 doi: 10.4274/MMJ.galenos.2024.76508
|
| 6 |
Grigorios Thermos, Nikolaos Katsoulas, George Vilos, Konstantinos I. Tosios. DPP4‐inhibitor‐associated oral mucous membrane pemphigoid. Oral Diseases 2023; 29(5): 2321 doi: 10.1111/odi.14234
|
| 7 |
Yuichiro Iwamoto, Takatoshi Anno, Katsumasa Koyama, Fumiko Kawasaki, Kohei Kaku, Koichi Tomoda, Seiko Sugiyama, Yumi Aoyama, Hideaki Kaneto. Case Report: Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.843480
|
| 8 |
Jie Huang, Xinxin Liu, Yingying Wei, Xinlu Li, Shupei Gao, Lingli Dong, Xiaoquan Rao, Jixin Zhong. Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.830863
|
| 9 |
Khaled R. Alkharsah, Salma Ali Aljaroodi, Jawad Ur Rahman, Awatif N. Alnafie, Reem Al Dossary, Reem Y. Aljindan, Amani M. Alnimr, Jamal Hussen, Ahmed S. Abdel-Moneim. Low levels of soluble DPP4 among Saudis may have constituted a risk factor for MERS endemicity. PLOS ONE 2022; 17(4): e0266603 doi: 10.1371/journal.pone.0266603
|
| 10 |
Faten Hadjkacem, Hamdi Frikha, Khouloud Boujelben, Chiraz Chaari, Emna Mnif, Abderrahmen Masmoudi, Tahia Boudawara, Hamida Turki, Mohamed Abid. Bullous Pemphigoid Associated With Dipeptidyl Peptidase-4 Inhibitors: A Case Report and Review of Current Evidence. Hospital Pharmacy 2023; 58(4): 357 doi: 10.1177/00185787231151861
|